Latest News about non/small cell lung cancer
Recent news which mentions non/small cell lung cancer
   EQRx's Lung Cancer Candidate Shows Improved Progression-Free Survival Versus Placebo
   
  August 08, 2022
  Tickers 
   EQRX
  
  
  From Benzinga
 
   The Evolution of Lung Cancer Research
   
  
  
 May 19, 2022
  From Benzinga
 
   Bristol Myers' Neoadjuvant Opdivo/Chemo Improves Event-Free Survival In Early-Stage Lung Cancer Patients
   
  April 11, 2022
  Tickers 
   BMY
  
  
  From Benzinga
 
   Cullinan Oncology Lead Cancer Program Shows Confirmed ORR Of 41% In Lung Cancer Setting
   
  March 29, 2022
  Tickers 
   CGEM
  
  
  From Benzinga
 From Benzinga
 
   Junshi Biosciences - Coherus Toripalimab Chemo Combo Met Survival Endpoints In Lung Cancer Setting
   
  March 15, 2022
  Tickers 
   CHRS
  
  
  From Benzinga
 From Benzinga
 
   Mirati Therapeutics' Adagrasib Application Under FDA Review For Lung Cancer Setting
   
  February 16, 2022
  Tickers 
   MRTX
  
  
  From Benzinga
 
   EQRx's Sugemalimab Shows Significant Overall Survival Benefit In Lung Cancer Settings
   
  January 19, 2022
  Tickers 
   EQRX
  
  
  From Benzinga
 
   Europe Approves Amgen's KRAS-Targeted Lung Cancer Therapy
   
  January 10, 2022
  Tickers 
   AMGN
  
  
  From Benzinga
 
   Merck's Keytruda As Adjuvant Treatment Improves Disease-Free Survival In Lung Cancer Setting
   
  January 10, 2022
  Tickers 
   MRK
  
  
  From Benzinga
 
   Genprex's Lead Cancer Program Scores Second FDA Fast Track Tag For Lung Cancer Setting
   
  
  
  January 03, 2022
  From Benzinga
 From Benzinga
 
   Janssen Secures Conditional EU Marketing Authorization For Rybrevant in Lung Cancer Setting
   
  December 13, 2021
  Tickers 
   JNJ
  
  
  From Benzinga
 
   Roche Posts Encouraging Follow-up Data From Tiragolumab/Tecentriq Trial In Lung Cancer
   
  
  
  December 10, 2021
  From Benzinga
 
   Roche's Gavreto Conditionally Approved In Europe For RET Fusion-Positive Lung Cancer
   
  
  
  November 19, 2021
  From Benzinga
 
   Iovance Shares Tumble After Cell Therapy Data From Lung Cancer Trial
   
  November 12, 2021
  Tickers 
   IOVA
  
  
  From Benzinga
 From Benzinga
 
   Bristol Myers' Opdivo Combo Meets Endpoint Goal In Lung Cancer Trial
   
  November 08, 2021
  Tickers 
   BMY
  
  
  From Benzinga
 
   Why Did Calithera Shares Dropped To 52-Week Low In Premarket Friday?
   
  November 05, 2021
  Tickers 
   CALA
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
